Reducing Symptom Distress in Patients with Advanced Cancer Using an e-Alert System for Caregivers: Pooled Analysis of Two Randomized Clinical Trials by Gustafson, David H. et al.
University of Kentucky
UKnowledge
Clinical Sciences Faculty Publications Clinical Sciences
11-14-2017
Reducing Symptom Distress in Patients with
Advanced Cancer Using an e-Alert System for
Caregivers: Pooled Analysis of Two Randomized
Clinical Trials
David H. Gustafson
University of Wisconsin - Madison
Lori L. DuBenske
University of Wisconsin - Madison
Amy K. Atwood
University of Wisconsin - Madison
Ming-Yuan Chih
University of Kentucky, mch266@uky.edu
Roberta A. Johnson
University of Wisconsin - Madison
See next page for additional authors
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/clinicalsci_facpub
Part of the Clinical Trials Commons, Health Communication Commons, Health Information
Technology Commons, and the Palliative Care Commons
This Article is brought to you for free and open access by the Clinical Sciences at UKnowledge. It has been accepted for inclusion in Clinical Sciences
Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Gustafson, David H.; DuBenske, Lori L.; Atwood, Amy K.; Chih, Ming-Yuan; Johnson, Roberta A.; McTavish, Fiona; Quanbeck,
Andrew; Brown, Roger L.; Cleary, James F.; and Shah, Dhavan, "Reducing Symptom Distress in Patients with Advanced Cancer Using
an e-Alert System for Caregivers: Pooled Analysis of Two Randomized Clinical Trials" (2017). Clinical Sciences Faculty Publications. 7.
https://uknowledge.uky.edu/clinicalsci_facpub/7
Authors
David H. Gustafson, Lori L. DuBenske, Amy K. Atwood, Ming-Yuan Chih, Roberta A. Johnson, Fiona
McTavish, Andrew Quanbeck, Roger L. Brown, James F. Cleary, and Dhavan Shah
Reducing Symptom Distress in Patients with Advanced Cancer Using an e-Alert System for Caregivers: Pooled
Analysis of Two Randomized Clinical Trials
Notes/Citation Information
Published in Journal of Medical Internet Research, v. 19, issue. 11, e354, p. 1-11.
©David H Gustafson, Lori L DuBenske, Amy K Atwood, Ming-Yuan Chih, Roberta A Johnson, Fiona
McTavish, Andrew Quanbeck, Roger L Brown, James F Cleary, Dhavan Shah.
This is an open-access article distributed under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work, first published in the Journal of Medical Internet
Research, is properly cited. The complete bibliographic information, a link to the original publication on
http://www.jmir.org/, as well as this copyright and license information must be included.
Digital Object Identifier (DOI)
https://doi.org/10.2196/jmir.7466
This article is available at UKnowledge: https://uknowledge.uky.edu/clinicalsci_facpub/7
Original Paper
Reducing Symptom Distress in Patients With Advanced Cancer
Using an e-Alert System for Caregivers: Pooled Analysis of Two
Randomized Clinical Trials
David H Gustafson1, PhD; Lori L DuBenske2, PhD; Amy K Atwood1, PhD; Ming-Yuan Chih3, PhD; Roberta A
Johnson1,4, MA, MAEd; Fiona McTavish1, MS; Andrew Quanbeck1,4, PhD; Roger L Brown5, PhD; James F Cleary6,
MD; Dhavan Shah7, PhD
1Department of Industrial and Systems Engineering, Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI,
United States
2Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States
3Department of Clinical Sciences, College of Health Sciences, University of Kentucky, Lexington, KY, United States
4Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI,
United States
5Nursing Research Department, School of Nursing, University of Wisconsin-Madison, Madison, WI, United States
6Medical Oncology Section, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United
States
7Mass Communication Research Center, School of Journalism and Mass Communication, University of Wisconsin-Madison, Madison, WI, United
States
Corresponding Author:
David H Gustafson, PhD
Center for Health Enhancement Systems Studies
Department of Industrial and Systems Engineering
University of Wisconsin-Madison
Mechanical Engineering Building, 4th Floor
1513 University Ave.
Madison, WI, 53706
United States
Phone: 1 6082395535
Fax: 1 6088901438
Email: dhgustaf@wisc.edu
Abstract
Background: Symptom distress in patients toward the end of life can change rapidly. Family caregivers have the potential to
help patients manage those symptoms, as well as their own stress, if they are equipped with the proper resources. Electronic health
(eHealth) systems may be able to provide those resources. Very sick patients may not be able to use such systems themselves to
report their symptoms but family caregivers could.
Objective: The aim of this paper was to assess the effects on cancer patient symptom distress of an eHealth system that alerts
clinicians to significant changes in the patient’s symptoms, as reported by a family caregiver.
Methods: A pooled analysis from two randomized clinical trials (NCT00214162 and NCT00365963) compared outcomes at
12 months for two unblinded groups: a control group (Comprehensive Health Enhancement Support System [CHESS]-Only) that
gave caregivers access to CHESS, an online support system, and an experimental group (CHESS+CR [Clinician Report]), which
also had CHESS but with a CR that automatically alerted clinicians if symptoms exceeded a predetermined threshold of severity.
Participants were dyads (n=235) of patients with advanced lung, breast, or prostate cancer and their respective family caregivers
from 5 oncology clinics in the United States of America. The proportion of improved patient threshold symptoms was compared
between groups using area-under-the-curve analysis and binomial proportion tests. The proportion of threshold symptoms out of
all reported symptoms was also examined.
Results: When severe caregiver-reported symptoms were shared with clinicians, the symptoms were more likely to be subsequently
reported as improved than when the symptoms were not shared with clinicians (P<.001). Fewer symptom reports were completed
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in the group of caregivers whose reports went to clinicians than in the CHESS-Only group (P<.001), perhaps because caregivers,
knowing their reports might be sent to a doctor, feared they might be bothering the clinician.
Conclusions: This study suggests that an eHealth system designed for caregivers that alerts clinicians to worrisome changes in
patient health status may lead to reduced patient distress.
Trial Registration: Clinicaltrials.gov NCT00214162; https://clinicaltrials.gov/ct2/show/NCT00214162 (Archived by WebCite
at http://www.webcitation.org/6nmgdGfuD) and Clinicaltrials.gov NCT00365963; https://clinicaltrials.gov/ct2/show/NCT00365963
(Archived by WebCite at http://www.webcitation.org/6nmh0U8VP)
(J Med Internet Res 2017;19(11):e354)   doi:10.2196/jmir.7466
KEYWORDS
Internet; health communication; palliative care; communication barriers; signs and symptoms; eHealth
Introduction
Managing Patient Symptom Distress
As advanced cancer treatments enable patients to live longer,
managing patient symptoms becomes even more important for
patients, informal (family or friend) caregivers, and clinicians
[1-5]. In some cases, the side effects of advanced treatment (eg,
pain and cognitive limitations) can create problems that
challenge the fabric of the family [6,7] and sometimes even lead
to conflict [6,7] between the family and the clinical team [8].
Some of the problem, from a patient and caregiver perspective,
revolves around when and how to get the attention of the clinical
team without “bothering” them [9].
Research has shown the importance of timely alerts to providers
regarding disconcerting changes in patient conditions. For
instance, a study of wait times in the Veterans Health
Administration system found that mortality rates increased
significantly when patients waited longer to be seen [10].
However, often changes in a patient’s symptoms are reported
only at a clinical visit and by then the patient’s condition is often
harder to manage than when the symptoms first worsened.
As early as 1997, family caregivers were estimated to provide
about US $200 billion of unpaid health care services [11].
Although the burden on family caregivers has been well
described [1], the potential of caregivers to improve their lives,
and patients’ and providers’ lives, has had comparatively little
attention. When properly engaged, the family caregiver can be
a critical source of information and support for both the patient
and the clinical team. Family caregivers often spend far more
time with the patient than anyone else. They can support the
patient while collecting information that could be vitally
important to providers and for effective care. Some families
assume these roles well with no help, whereas others need
support to realize their potential. The system studied here was
designed to help caregivers maximize their value as a partner
in care and minimize their burden.
Recent developments in electronic symptom collection systems
[12,13] offer promise for more timely and accurate information,
greater patient acceptance, and reduced cost compared with
paper-based systems [14]. Studies of such systems have shown
moderate to significant improvement of patient symptoms and
quality of life [15-19], and even survival [20]. A key issue is
when and how to reach clinicians effectively, given how busy
they are.
This problem of reporting symptom changes to clinicians is
exacerbated for advanced cancer patients. These patients find
it increasingly difficult or impossible to use symptom-reporting
systems as their disease advances. Informal caregivers are in a
position to accurately observe and report on patient symptoms
[21-23].
The CHESS System With Reports to Clinicians
The Comprehensive Health Enhancement Support System
(CHESS) refers to extensively tested information and
communication technologies for coping with cancer and other
serious illnesses. The vast majority of CHESS systems have
been designed for patients [24-27]. The CHESS "Coping with
Cancer" website [28] was designed instead for caregivers to (1)
provide them with well-organized cancer, caregiving, and
bereavement information, (2) serve as a channel to communicate
with and receive support from other caregivers, experts,
clinicians, and their social networks, (3) act as a coach by
gathering information from caregivers and providing feedback
based on algorithms (decision rules), and (4) provide tools (eg,
a program to organize support from family and friends) to
improve the caregiving experience. Hence the content and focus
of this caregiver program differed substantially from other
CHESS systems. The relationship between theory and CHESS
was previously reported [29].
The CHESS caregiver system studied in this analysis contained
a symptom-reporting system, the Clinician Report (CR), which
delivered to the clinical team information about worrisome
changes in symptoms collected from informal caregivers of
advanced-stage cancer patients [29-31]. Specifically, the CR
contacted the clinical team whenever a threshold symptom was
reported—that is, when a caregiver rated at least one of 10
patient symptoms at ≥7 on a 0 to 10 severity scale. The alert
was intended to quickly bring clinician attention to severe
symptoms, potentially leading to timelier symptom management.
Purpose and Contribution of the Study
The study reported here is, to our knowledge, the first to report
the effects on patients of an electronic system that collects and
analyzes caregiver observations and sends alerts to clinicians
when caregivers report worrisome increases in symptom distress
in patients suffering from advanced cancer. A previous paper
reported the effects on caregivers themselves of using the system
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[30]. In that study, caregivers with CHESS+CR had less negative
mood at both 6 and 12 months than caregivers in the
CHESS-Only group. The groups did not differ significantly on
caregiver preparedness or physical burden at either time point.
This paper reports the effects of the system on patients,
specifically on patient symptom distress. We examined two
outcomes: (1) the proportion of improved caregiver-reported,
severe (“threshold”) symptoms that patients had out of all
threshold symptoms and (2) the proportion of caregiver-reported
threshold symptoms that patients had out of the total symptoms
reported on. Specifically, the study addresses this question:
Does the CHESS system with the CR reduce symptom distress
in patients more than CHESS without the CR?
Methods
Participants
Between September 2004 and April 2007, 235 dyads of patients
with advanced-stage cancer and their primary informal
caregivers were recruited to one of two randomized clinical
trials of CHESS. One of the trials recruited breast and prostate
cancer patients and their caregivers (NCT00214162); the other
enrolled lung cancer patients and caregivers (NCT00365963).
Eligible breast cancer patients were women with recurrent or
metastatic breast cancer. Eligible prostate cancer patients had
hormone refractory or metastatic prostate cancer. Eligible lung
cancer patients included those in stage IIIA, IIIB, or IV disease.
Caregivers were at least 18 years of age and identified by the
patient as their primary source of physical, emotional, or
financial support.
Recruitment
Recruitment sites were 5 cancer centers in the Northeastern,
Midwestern, and Southwestern United States. This analysis
contains a combined sample from both clinical trials of 117
dyads in the CHESS-Only group and 118 in the CHESS+CR
group (Figure 1). Details about recruitment, randomization, and
procedures were previously reported [28,30].
The attrition rate in this study (33.6%, 36/107) in the
CHESS-Only group and 38.1% (42/110) in the CHESS+CR
group) is comparable with other clinical trials of patients with
advanced cancer. A review of 18 interventional supportive and
palliative oncology trials found an attrition rate of 44% at study
end [32].
Interventions
Both the CHESS-Only and CHESS+CR participants received
access to CHESS. CHESS was designed for caregivers, but
patients could have access as well if they wanted it. Upon initial
log-in and every 7 days after, caregivers were prompted when
logging into CHESS to complete a check-in with questions
about patient symptom status from a modified Edmonton
Symptom Assessment Scale (ESAS) [33]. Check-in items had
to be completed before advancing to another page in the CHESS
website. Items on check-ins after the first check-in were
populated with previous ratings; caregivers needed to respond
only if a rating changed. In the CHESS-Only group, the
information reported at check-in was intended for caregivers
and not sent to clinicians. In the CHESS+CR group, CHESS
summarized the caregiver-provided information and made it
available (with patient permission) to the clinical team [31].
Alerts were emailed, faxed, or phoned (according to clinician
preference) to a designated member of the clinical team,
typically a nurse, (1) when a threshold symptom was reported
and (2) 2 days before a scheduled clinic visit. The severity
threshold for an alert was set at 7, based on Serlin et al [34],
indicating that this symptom distress level interferes significantly
with a patient’s life. Alerts included patient name, the symptom
or symptoms of concern, and worrisome symptom rating(s),
along with a link to the CHESS+CR website to view the
complete CR, including ratings over time. At any time, clinicians
in the CHESS+CR group could also access the full CR by
logging onto CHESS+CR.
Procedures
The trials were approved by the institutional review boards at
each recruitment site. Oncology clinicians were consented and
agreed to receive alerts.
Figure 1. Participant flow.
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After caregivers and patients completed the consent form and
pretest, a random number generator at the University of
Wisconsin randomly assigned dyads to CHESS-Only or
CHESS+CR (1:1 ratio). Randomization was blocked by dyad
relationship (spouse or partner vs nonspouse or partner) and
race (white vs non-white). All caregivers who needed a computer
were mailed a laptop with Internet access and a user manual.
Participants who already had a computer with Internet access
were reimbursed for Internet access during the study period.
Caregivers (and patients, if they wished to use CHESS) were
assigned a unique code name and password for accessing
CHESS. Technical support was available by telephone. CHESS
staff provided training on using CHESS via telephone or in
clinic. Those in the CHESS+CR group were told that symptoms
reported as “high” would trigger an email to the clinical team.
Participants were not told the threshold, but when they gave a
rating of ≥7, they were encouraged to call the clinic and notified
on the website that the clinical team would be alerted.
Although caregivers and patients were enrolled as dyads,
caregivers were the target population in both clinical trials. The
analysis uses data from all 12 months of the breast and prostate
cancer intervention and, to standardize data from the two trials,
from the first 12 months of the 24-month lung cancer
intervention. The CHESS website server generated a log file
for storing the symptom ratings, who reported the ratings, when
the ratings were reported, and whether an alert was sent. These
data were retrieved and analyzed for this study.
Measures
Patient distress is a subjective measure that was assessed at
check-in by a modified ESAS [30] on a 0 to 10 scale, with 10
indicating the greatest symptom distress. On the basis of the
feedback from oncologists, we replaced 3 physical items in the
original scale [33] (activity, drowsiness, and well-being) with
three common cancer symptoms (fatigue, constipation, and
diarrhea). The modified ESAS contained 10 items. This analysis
focuses on individual ratings for each of the 10 symptoms rather
than on a single scale score calculated across symptoms.
Improvement was determined separately for each threshold
symptom by comparing subsequent ratings given by the same
person at check-in. A threshold symptom was considered
improved if it was rated lower at the next check-in (eg, if a
caregiver rated patient pain at 9 one week and 8 the next week,
the symptom was considered improved; likewise, a symptom
rated at 7 one week and 6 the next was considered improved).
Patient symptom ratings given in the last check-in were not
examined because no follow-up check-in could be compared
with it. Patients and caregivers who completed fewer than two
check-ins were excluded in the analysis because they supplied
no data for comparison.
To evaluate the impact of the CR on symptom change,
caregiver-reported check-in data were aggregated in six 2-month
periods (eg, months 3 and 4). This interval is somewhat
arbitrary. It was chosen because caregivers in the two
randomized trials from which the data came filled out written
surveys every 2 months. The following values were calculated:
(1) number of assessed symptoms (number of discrete symptoms
rated during a 2-month period, calculated as the number of times
a check-in was completed multiplied by 10 because each
check-in assessed 10 symptoms), (2) number of patient threshold
symptoms (number of symptoms rated ≥7), and (3) number of
improved patient threshold symptoms (number of threshold
symptoms with a lower rating in the next check-in). Group totals
of the foregoing three variables were used to calculate the
following two proportion indices for each 2-month period as
well as the entire 12-month study period. Our primary interest
was the proportion of improved caregiver-reported patient
threshold symptoms (number of improved threshold symptoms
out of the total number of threshold symptoms, which shows
the impact on symptom management). We also calculated the
proportion of caregiver-reported patient threshold symptoms
(number of caregiver-reported threshold symptoms out of the
total number of symptoms that were reported on). The purpose
of the second proportion was to examine whether knowledge
that their data might be reported to the clinical team would affect
reporting behavior.
Statistical Analysis
To compare the two outcomes of interest between groups over
time (ie, improved patient threshold symptoms and proportion
of patient threshold symptoms), the area under the curve (AUC)
was calculated based on group-aggregated values. The AUC
per group was calculated using the trapezoidal rule in NCSS
2007 [35]. Group differences in AUC were assessed by
converting group AUC into a relative proportion per group and
then conducting a proportional difference test (StatXact 5, Cytel)
[36]. In addition, aggregated symptom reports were averaged
across the 12 months. Differences in these averaged improved
threshold symptoms and proportions of threshold symptoms
were tested using the same method. The standardized statistics,
P value and 95% CIs, were calculated based on methods outlined
by Miettinen and Nurminen [37] and Chan and Zhang [38]. To
test for potential response bias after group assignment, the
proportion of patient threshold symptoms reported by caregivers
at pretest was compared with the proportion at the first check-in
using the multiple-sample McNemar test [39]. All tests were
conducted at alpha=.05 level.
Results
Baseline Demographics and ESAS Ratings
Table 1 shows demographics and pretest ESAS ratings for the
two groups. Among patients, 55.8% (121/217) were female,
with an average age of 63 years. Caregivers were predominantly
female (64.2%, 140/217), with an average age of 56 years. Most
caregivers (69.3%, 150/217) were spouses or partners.
Demographic characteristics of caregivers omitted from the
analysis (ie, caregivers who submitted fewer than two check-ins)
were similar to those of caregivers included in the analysis
except on caregiver gender, for which 53% of excluded
caregivers and 71% of included caregivers were female (χ21=6.4
P=.01). In the 12-month period, the proportion of patient
symptoms reported by caregivers at least twice did not differ
by randomization group (CHESS-Only, 71/107, 66.4% vs
CHESS+CR, 68/110, 61.8%, standardized difference Z=0.696,
P=.49, 95% CI −.082 to .171).
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Table 1. Demographics of participants who received the interventions.
CHESS+CRb (n=110)CHESSa-Only (n=107)Characteristics
Cancer type, n (%)
44 (40)45 (42)Breast
34 (31)30 (28)Prostate
32 (29)32 (30)Lung
Patients
62.73 (11.00)d62.53 (9.63)cAge, mean (SD)
Gender, n (%)
49 (45)47 (44)Male
61 (55)60 (56)Female
Caregivers
56.36 (13.39)e55.73 (13.02)cAge, mean (SD)
Gender, n (%)
69 (63)71 (66)Female
Relationship to patient, n (%)
75 (68)75 (70)Spouse
35 (32)32 (30)Nonspouse
Caregiver annual household income in US dollars, n (%)
35 (32)c35 (33)Below $40,000
36 (33)37 (35)$40,001-$80,000
28 (25)26 (24)$80,001 and over
11 (10)9 (8)Didn’t report
3.67 (1.52)d3.96 (1.58)gCaregiver education (1-6)f, mean (SD)
2.36 (1.37)e2.57 (1.26)iCaregiver Internet comfort (1-4)h, mean (SD)
28.13 (15.90)i27.75 (16.82)lCaregiver-reported patient ESASj (1-90)k, mean (SD)
aCHESS: Comprehensive Health Enhancement Support System.
bCR: Clinician Report.
cn=105.
dThese values were based on pretests of 109 caregivers in CHESS+CR group because 1 caregiver did not return the pretest survey.
en=107.
fCaregiver education levels: 1 Stopped school before finishing high school; 2 High school degree; 3 Some college courses; 4 Associate or technical
degree (2-year college); 5 Bachelor’s degree (4 year college); 6 Graduate degree.
gn=106.
hInternet comfort levels: 0 Not at all; 1 A little; 2 A medium amount; 3 Quite a bit; 4 Extremely.
in=102.
jESAS: Edmonton Symptom Assessment Scale.
kCalculated as the sum of severity ratings (0=none; 10=worst possible) across 9 items.
ln=94.
mn=101.
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Table 2. Bimonthly summary of caregiver-reported patient symptom indices. At pretest, ESAS items were rated via paper survey. The report of a
threshold symptom did not produce a clinician alert.
CHESS+CRbCHESSa-OnlyRandomization group
118117Pretest
104101Month 2
9396Month 4
8588Month 6
7478Month 8
6872Month 10
6365Month 12
aCHESS: Comprehensive Health Enhancement Support System.
bCR: Clinician Report.
We also examined data about participant use of the system to
see whether different participants used the system differently
(ie, by gender, race, age, living situation, education, employment
status, or income) and found no statistically significant
difference.
Symptom Indices and Proportion of Threshold to All
Assessed Symptoms
Table 2 shows patient symptom indices reported by caregivers
calculated for each 2-month period and totaled across 12 months.
Table 3 reports on the number of patient threshold symptoms
reported by caregivers as a proportion of all assessed symptoms.
At pretest, for instance, CHESS-Only caregivers reported on
symptoms 1026 times, and 182 of those symptoms (17.74%)
met or exceeded the threshold. CHESS+CR caregivers reported
1056 symptoms, and 184 (17.42%) were threshold symptoms.
The effect size of the difference between CHESS-Only and
CHESS+CR was 0.01. Effect sizes were determined by using
Cohen arcsine transformation of the probabilities [40]. At
pretest, there were no significant differences between groups,
but differences emerged (caregivers in CHESS+CR reported
fewer symptoms) with what Cohen describes as a small effect
size.
Proportion of Improved Threshold Symptoms to All
Threshold Symptoms
Table 4 reports on the number of improved threshold symptoms
as a proportion of all threshold symptoms reported. For instance,
at 2 months, the CHESS-Only caregivers reported 385 threshold
symptoms, 103 of which (26.8%) were subsequently reported
as improved. By contrast, at the same time point, CHESS+CR
caregivers reported 212 threshold symptoms, 113 of which
(53.3%) were subsequently reported as improved. Comparing
CHESS vs CHESS+CR across all posttest time periods yielded
a moderate effect size of 0.60 in favor of CHESS+CR.
Analyses of average aggregated proportions across all 12 months
(the Total column of Tables 3 and 4) show similar findings: the
CHESS+CR group was more likely to report improvement
(53.04% vs 26.16%, Wald Z-test=10.35, P<.001, 95% CI .216
to .320) but less likely to report threshold symptoms (7.7% vs
14.4%, Wald Z-test=−12.27, P<.001, 95% CI −077 to −057).
That is, throughout the study period, caregivers in the
CHESS+CR group consistently reported that their patients had
less symptom burden and better symptom management than
patients in CHESS-Only group.
Table 3. Proportion of threshold symptoms/all assessed symptoms and effect sizes.
Effect size (95% CI)CHESS+CRb, n/N (%)CHESSa-Only, n/N (%)Randomization group
0.01 (0.00-0.02)184/1056 (17.42)182/1026 (17.74)Pretest
0.18 (0.17-0.19)212/2380 (8.91)385/2620 (14.69)Month 2
0.26 (0.23-0.28)83/1240 (6.70)263/1820 (14.45)Month 4
0.18 (0.16-0.21)74/840 (8.81)219/1490 (14.70)Month 6
0.19 (0.14-0.25)34/550 (6.2)133/1140 (11.67)Month 8
0.28 (0.21-0.36)26/390 (6.7)140/910 (15.38)Month 10
0.41 (0.27-0.55)14/350 (4.0)129/830 (15.54)Month 12
0.216 (0.221-0.220)443/5750 (7.70)1269/8810 (14.40)Total
aCHESS: Comprehensive Health Enhancement Support System.
bCR: Clinician Report.
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Table 4. Proportion of improved threshold symptoms/all threshold symptoms and effect sizes.
Effect size (95% CI)CHESS+CRc, n/N (%)CHESSa-Only, n/N (%)Randomization group
N/AN/AN/AbPretest
0.55 (0.52-0.57)113/212 (53.3)103/385 (26.8)Month 2
0.57 (0.52-0.62)44/83 (53)67/263 (25.5)Month 4
0.60 (0.55-0.66)41/74 (55)53/219 (24.2)Month 6
0.42 (0.30-0.56)17/34 (50)39/133 (29.3)Month 8
0.64 (0.48-0.79)14/26 (54)33/140 (23.6)Month 10
0.30 (0.04-0.64)6/14 (43)37/129 (28.7)Month 12
0.60 (0.59-0.62)235/443 (53.0)332/1269 (26.16)Total
aCHESS: Comprehensive Health Enhancement Support System.
bN/A: not applicable.
cCR: Clinician Report.
Examination of Possible Response Bias
Caregivers in the CHESS+CR group reported a lower proportion
of threshold symptoms at each 2-month period (Table 3). It may
be that they felt they might be bothering the doctor or that word
would get back to the patient that the caregiver thought the
patient was doing poorly. To examine whether caregivers ranked
symptoms lower to avoid triggering the alert to the clinician,
we compared symptom ratings at pretest with those at the first
online check-in, assuming any reluctance to alert the clinician
would not have been present on pretest because pretest data
were not sent to clinicians and patients knew this. A
multiple-sample McNemar test [39] was used to test for
differences between the CHESS-Only and CHESS+CR caregiver
groups on changes in reporting threshold symptoms from pretest
to first online check-in. A total of 1329 symptoms were rated
by 135 caregivers (70 CHESS-Only, 65 CHESS+CR) at pretest
and first online check-in and were used in this analysis. At
pretest, no significant difference was found between randomized
groups in the number of patient threshold symptoms reported
(Z=0.189, P=.85, 95% CI −0.03 to 0.04), but the difference in
reporting threshold symptoms from pretest to first online
check-in was statistically significant (Z=6.910, P<.001, 95%
CI 6.50 to 7.29), with CHESS+CR caregivers reporting a lower
proportion of threshold symptoms at first check-in than at pretest
(Table 5), suggesting that CHESS+CR caregivers may have had
a response bias toward lower ratings when they knew a clinician
might be alerted.
Further analyses also suggest that bias may help explain the
results. First, we examined the relationship between caregiver
demographics and the likelihood of reporting symptom data in
the CHESS-Only versus CHESS+CR groups. Gender was the
only statistically significant characteristic related to the reporting
of symptoms: 64.7% (172/266) of women are reporters overall
versus 49.4% (131/266) of men; χ21
 (N=266)=5.2, P=.02. In the
CHESS+CR group, 64.4% (75/117) of women versus 45.5%
(53/117) of men were reporters, χ21
 (N=117)=4.02, P=.045; no
significant differences were found in the CHESS-Only group.
We also looked at 35 outcomes, such as caregiving burden and
patient quality of life at each survey time frame, and did not
find a consistent difference between caregivers who reported
symptoms and those who did not.
We also examined, in addition to improved symptoms, which
were the focus of the study, the proportion of symptoms that
stayed at the same level of severity and the proportion that
worsened. Caregivers in the CHESS-Only group reported more
total symptoms (8810) and a greater proportion of threshold
symptoms (14.40%, 1269/8810) than caregivers in the
CHESS+CR group (5750 total symptoms, of which 7.70%
[443/5750] were threshold symptoms). Caregivers in the
CHESS+CR group reported a much higher percentage of
improved threshold symptoms (53.0% [235/443] versus 26.16%
[332/1269] in the CHESS-Only group), a slightly larger
percentage of worsened symptoms (14.0% [62/443] versus
10.40% [132/1269] in the CHESS-Only group), and a much
lower percentage of threshold symptoms with no change (33.0%
[146/443] versus 63.4% [805/1269] in the CHESS-Only group).
Finally, we looked at how many caregivers reported symptoms
in the 2 groups. Over the 12 months, 71 caregivers reported the
8810 symptoms in the CHESS-Only group compared with 68
caregivers in the CHESS+CR group, who reported on 5750
symptoms. On average, each reporting caregiver in the
CHESS-Only group reported on 124.1 symptoms whereas
caregivers in CHESS+CR group reported an average of 84.6
symptoms. Hence, a 31.8% difference exists between the groups
in the average number of symptoms reported per caregiver, with
those in the CHESS+CR group reporting fewer.
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Table 5. Proportion of patient threshold symptoms reported by caregivers at pretest versus initial check-in.
P valueEffect size (95% CI)CHESS+CRb, n/N (%)CHESSa-Only, n/N (%)Randomization group
.850.02 (0.00-0.04)105/645 (16.3)106/684 (15.5)Pretest
<.0010.15 (0.12-0.18)70/645 (10.9)108/684 (15.8)Initial check-in
aCHESS: Comprehensive Health Enhancement Support System.
bCR: Clinician Report.
Discussion
Principal Findings
The CR was designed to speed information about patient
symptoms to clinicians by automatically sending an alert when
a caregiver reported a symptom to be at or over a threshold.
With immediate symptom reporting, clinicians can intervene
rapidly and reduce patient symptom distress. Our results show
that for symptoms causing severe (≥7 on a 0 to 10 scale) distress,
patients whose caregivers had access to CHESS+CR, and
therefore had an alert sent to their clinicians, had a greater
proportion of symptom improvements than those with
CHESS-Only, whose clinicians did not receive alerts or have
access to ratings. These results suggest that the CR may facilitate
patient symptom improvement and management. A previously
published paper [30] found that the same system, CHESS+CR,
improved caregivers’ negative mood, suggesting that one
electronic health (eHealth) system may help both caregivers
and indirectly the patients themselves.
Possible Explanations of the Results
The effects of the CR may be explained in various ways, as
clinicians explained in qualitative interviews [31], which include
the following:
1. The CR could help clinicians better prepare to address
patient symptoms and caregiver concerns in clinic visits.
2. The CR may boost caregiver efficacy in discussing
symptoms with clinicians.
3. The CR may deepen caregiver involvement because
caregivers can monitor patient symptoms and report their
concerns directly to the clinical team.
4. The CR may enable earlier intervention because the severe
symptom distress that triggers alerts might otherwise be
unreported and therefore not attended to.
The overall assessed symptom rate in the CHESS+CR group
dropped significantly more than in the CHESS-Only group. A
response bias may have occurred if caregivers avoided using
the check-in or rated symptoms lower because they feared
bothering the clinician [41] or upsetting the patient. The finding
that symptom distress was equal between the two study groups
at pretest but lower in the CHESS+CR group at first check-in
supports this explanation. The examination of other factors that
may account for the difference between the groups in
caregiver-reported symptoms (ie, demographic differences
between caregivers in the two groups, the proportion of
symptoms that stayed the same and worsened in each group,
and the number of caregivers reporting symptoms in each group)
corroborates the suggestion of bias among the CHESS+CR
caregivers to report fewer symptoms.
The lower overall assessed symptom rate in the CHESS+CR
group may also be explained by clinician response. Clinicians
were given no directions about how to respond to CR alerts. If
clinicians did not respond (we do not know whether they did),
participants may have stopped using the CR, although the data
suggest that when the CR alerts the clinician, the symptoms are
more likely to improve. It may be that clinicians responded to
alerts by addressing the symptoms more promptly, scheduling
additional patient visits, or responding differently to patients
during visits, though we lack the data to explore this. Future
research on caregiver and patient motives for using or not using
a symptom reporting system could better inform system
development and dissemination.
Limitations
The study has limitations. Data collection was completed in
2009. We do not see this as a major limitation because the
influence of caregiver input on clinical decision making is rarely
examined, and the result of such input, as shown in this paper,
can be significant for patients. In fact, because reports based on
the regular collection of both patient and caregiver data are
beginning to appear more frequently, the methods and results
reported here are more likely to be timely now than several
years ago.
Each institution had a small number of clinicians, and they were
not randomized. The effect of the CR on symptom improvement
could potentially be greater than demonstrated here because
clinicians seeing patients in both groups may have improved
their symptom management with control-group patients as a
result of changes they made with the intervention group. Future
research could avoid this by randomizing clinics or clinicians
rather than caregiver/patient dyads within clinics, although this
approach could confound clinic variability in care with
randomization.
Furthermore, all outcome variables were self-reported. Medical
records could have been used to validate self-reports, for
example, by observing whether interventions seemed to respond
to reported threshold symptoms, such as a change in the type
or amount of medication if high pain levels were reported. Such
an analysis was outside the scope of the study.
Although clinicians participated in qualitative interviews [31]
(results are summarized above under Possible Explanation of
the Results), a distinct weakness of the paper is the lack of
qualitative evidence from caregivers and patients. For example,
qualitative assessment could also have been used to explore the
apparent bias in the CHESS+CR group about “bothering” the
doctor.
Although the study suggests the potential of CR-like systems
to enhance patient care and speed recovery from distressing
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symptoms, further research with different patient populations
would help validate and improve the generalizability of these
findings. In addition, widespread use of such a system poses
important challenges—cost, risk aversion, clinician time, and
interoperability with the electronic health record (EHR).
Caregivers could use such a system on their smartphones, which
are becoming ubiquitous. Yet maintaining such an eHealth
system has fixed costs (eg, for updating content and moderating
discussions). These costs could be borne by health systems and
insurers if outcomes warrant it, given the new financing models
that reward governmental agencies to pay for systems that
improve outcomes and the increasing use of fixed payments to
providers. The human tendency to avoid risk and stay with the
familiar works against innovations such as CR-like systems, as
does the time pressure clinicians contend with. Because
clinicians worry about innovations that add work and reduce
time with patients, systems must be built to minimize burden.
Finally, as we have discovered in subsequent studies, getting
information from such a system into the EHR can be extremely
difficult. However, this is important and should be done so that
clinicians can access information from patient and caregiver
eHealth systems without going to a website outside the EHR.
Conclusions
The significance of this study is its finding that eHealth support
helped caregivers play a more effective role in their loved one’s
care than the role they played without that support. Furthermore,
the results suggest that eHealth alerts coming from family
caregivers can influence clinician behavior. Together, these
findings suggest that eHealth-based CRs from caregivers can
influence care for patients with many types of cancer, as well
as chronic conditions such as metabolic syndrome, addiction,
human immunodeficiency virus, and Alzheimer disease [42,43].
Further research is required to address this speculation.
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